Every Particle Matters at Coriolis Pharma

Particle Identification Tailored to Your Needs

Observing visible and subvisible particles can stagnate the drug development or the batch release process. Coriolis Pharma has the experience and the capacity to determine the identity and possible origin of particulate matter in your biopharmaceutical drug products—crucial for troubleshooting and root-cause analysis.

For more information visit our Particle Identification services page. Our experts can analyze your samples with minimal lead time and deliver results from the lab bench so you can resolve the underlying cause of particle formation.